Crohn's disease is the generic name for regional enteritis, which is a type of Irritable Bowel Disease. The initial onset of this disease is between the ages of 15 to 30 years old with about 4 out of 1000 people being affected (CDC, 2014). The CDC (2014) also states that the United States has a “1.7 billon dollar” annual financial burden resulting from ”700,000 physician visits, 100,000 hospitalizations, and disability in 119,000 patients” yearly. There is presently no cure for Crohn's, although certain medications and treatments have been proven to take the disease into remission. Crohn’s disease is a realitivly new disease, without a cure, than can be controlled and let the patient live a normal life.
...at are firmly settled in their patriarchal ways, there are many countries that are shying away from this continuity. It seems that these countries will continue to benefit their female populations. After all, much is said about the popular view of gender disparity simply by the plethora of articles written. While some countries may accept genital mutilation, abuse, or denied education, many others do not. Admittedly, the worst of the unequal treatment occurs in non-democratic (i.e. the Middle East) or extremely corrupt (i.e. India) governments. And, many of the more equal opportunities for women—equal pay and unrestricted militant careers—are in the U.S. Based on these articles, women in the developed world may gain more and more parity, while women in less developed countries face a much more difficult battle. Maybe someday, we will reach egalitarianism again.
Turner, B. J., Newschaffer, C. J., Zhang, D., Fanning, T., & Hauck, W. W. (1999). Translating clinical trial results into practice. Annals of Internal Medicine, 130(12), 979-986.
This information was published by the government and had a sample size of ‘1033’ people, also Isoniazid chemoprophylaxis was used for 18 months; more than twice the duration that isoniazid in combination with other drugs would be used in treatment today. So patients may be less likely to develop symptoms. Although this trial is old, it is very reliable as it has a large sample size and is unbiased as the information is from a MEDLINE database. Also as this was a large study, it can be assumed it was carried out fairly and there w...
As you can see there are a few common mispellings of Crohn 's Disease. The definition of Crohn 's Disease is a chronic inflammatory disease of the intestines, especially the colon and ileum (the 3rd portion of the small intestine, between the jejunum and the cecum), associated with ulcers and fistulae (an abnormal or surgically made passage between a hollow or tubular organ and the body surface, or between two hollow or tubular organs). In layman terms the definition of Crohn 's Disease is best explained as The body 's immune system tries to cure the digestive tract, but the digestive tract does not really need curing because it is not sick. The tissue of the digestive tract then becomes inflamed. The inflammation starts to eat away at the lining o...
This source is a research paper on a experimental investigation done on women in a published journal. In this investigation, three groups of women are exposed to fashion with brand names. The three groups were one with no labeling, one with a short warning label, and one with an explanative warning label. The investigation showed that the group with a short warning label felt the less body dissatisfaction and were able to recall more of the brand names whereas the group with an explanative warning label couldn’t be bothered to read the whole labeling and the control group (without any labeling) both felt a greater level of body dissatisfaction. I will use this source ...
Schneider, Matthias and Klaus Kruger. “Rheumatoid Arthritis—Early Diagnosis and Disease Management.” Deutsches Aerzteblatt International 110.27/28 (2013): 477-484. CINAHL Plus with Full Text. Web. 25 Jan. 2014
Crohn’s disease is a chronic disorder of the digestive system. I can affect any area of the gastrointestinal system from the mouth to the anus. Its inflammatory process may spread to include skin, eyes, joints, mouth and sometimes the liver (Chang, 2008). Males and females appear to be affected proportionately. Crohn’s disease can occur in people of any age, but it is mostly a disease of adolescents and young adults. However, Crohn’s disease may occur in people over 70 years old and in young children (Crohn’s & Colitis Foundation of America, 2009).
Hahn, Y. & Kim, J. (2010, November 30). Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis. Korean Journal of Pediatrics. 53(11). doi: 10.3345/kjp.2010.53.11.921
Dawes, Nickki, et al. "Mexican-Origin Youth Participation In Extracurricular Activities: Predicting Trajectories Of Involvement From 7Th To 12Th Grade." Journal Of Youth & Adolescence 44.11 (2015): 2172-2188. Academic Search Complete. Web. 8 Feb. 2016.
DrugM. Del Tacca, R. Colucci, M. Fornai, C. Blandizzi - Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Disclosures - Clin Drug Invest. 2002;22(12)
A randomized trial of ondansetron for the treatment of irritable bowel syndrome with diarrhea, was a two-centre, double-blind, placebo controlled crossover study of ondansetron 4 mg/tablet versus placebo. The inclusion criteria of the study were age 18–75 years, IBS-D patients meeting the Rome III criteria, women of childbearing age should agree to have contraception during the study, no evidence of inflammatory bowel disease/microscopic colitis and able to give informed consent. The exclusion criteria were pregnancy or br...
Garnett, AM 2012, ‘The effect of the resources boom on the population and labour market of Western Australia’, Economic Papers, vol. 31, no. 1, pp. 63-75
New emerging therapy has been introduced for CD especially biologic agents, which is commonly reserved for moderate to severe Crohn’s.1 Most of the biologic agents used in the treatment of CD belongs to the family of tumour necrosis factor alpha (TNFα) antagonist.17 This has made it complicated for doctors who are treating patients that are not responding to the drugs, which belongs to this family group.17 Nonetheless, there has been a huge improvement in the management of these patients with the recent introduction of the new biological agent like ustekinumab, which has a different mechanism of actions (MOA) from TNFα antagonists.18